CYP-Mediated Clozapine Interactions: How Predictable Are They?

Chetty, Manoranjenni; Murray, Michael
May 2007
Current Drug Metabolism;May2007, Vol. 8 Issue 4, p307
Academic Journal
Despite the introduction of newer drugs, the atypical antipsychotic clozapine remains the most effective drug in psychotic patients who are resistant to treatment with conventional agents. Optimal therapeutic responses to clozapine have been reported with serum concentrations between 350 μg/L and 1000 μg/L. Clozapine is frequently combined with other drugs to enhance efficacy and reduce adverse reactions but pharmacokinetic interactions can have a significant impact on drug response. The majority of the interactions with clozapine are reported to be mediated by cytochrome P450 (CYP) enzymes. CYP1A2 has a major role in the oxidative metabolism of clozapine, with a minor contribution from CYP3A4, and possibly CYP2D6, CYP2C9 and CYP2C19. Interactions mediated by potent CYP1A2 inhibitors (such as fluvoxamine) or inducers (like cigarette smoke) appear to be consistent, predictable and usually clinically significant. There are many case reports of interactions between clozapine and weak CYP1A2 inhibitors or inducers which are also potent inhibitors or inducers of CYP3A4 or CYP2D6. Researchers often explain these observations on the basis of the CYP1A2 involvement. In addition, there are case reports of clinically significant interactions between clozapine and drugs that are not substrates, inhibitors or inducers of CYP1A2. These interactions are difficult to predict and may not be consistent, as reflected by the conflicting literature reports. Further research to elucidate individual differences in clozapine metabolism, with the potential to detect the dominant roles of CYPs other than CYP1A2, may assist us in predicting these interactions.


Related Articles

  • Metabolism of Atypical Antipsychotics: Involvement of Cytochrome P450 Enzymes and Relevance for Drug-Drug Interactions. Urichuk, Liana; Prior, Trevor I.; Dursun, Serdaqr; Baker, Glen // Current Drug Metabolism;Jun2008, Vol. 9 Issue 5, p410 

    The involvement of cytochrome P450 (CYP) enzymes in the metabolism of the atypical (second-generation) antipsychotics clozapine, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole, paliperidone and amisulpride is reviewed, and the possible relevance of this metabolism to drug-drug...

  • Drug-Herb Interaction: Effect of St John's Wort on Bioavailability and Metabolism of Procainamide in Mice. Dasgupta, Amitava; Hovanetz, Melissa; Olsen, Margaret; Wells, Alice; Actor, Jeffrey K. // Archives of Pathology & Laboratory Medicine;Jul2007, Vol. 131 Issue 7, p1094 

    Context.-St John's wort induces the activity of the cytochrome P450 enzyme system causing treatment failure because of increased metabolism of many drugs. Procainamide is metabolized by a different pathway to N-acetyl procainamide. Objective.-To study St John's wort—procainamide...

  • Interactions between the cytochrome P450 system and the second-generation antipsychotics. Prior, Trevor I.; Baker, Glen B. // Journal of Psychiatry & Neuroscience;Mar2003, Vol. 28 Issue 2, p99 

    Awareness of the metabolism of second-generation antipsychotics by the cytochrome P450 (CYP) system can inform the clinician about how to avoid and manage drug-drug interactions involving these enzymes. Clozapine is metabolized primarily by CYPIA2, with additional contributions by CYP2CI9,...

  • Clinically Significant Drug Interactions with Atypical Antipsychotics. Kennedy, William Klugh; Jann, Michael W.; Kutscher, Eric C. // CNS Drugs;Dec2013, Vol. 27 Issue 12, p1021 

    Atypical antipsychotics [also known as second-generation antipsychotics (SGAs)] have become a mainstay therapeutic treatment intervention for patients with schizophrenia, bipolar disorders and other psychotic conditions. These agents are commonly used with other medications—most notably,...

  • Disposition Pathway-Dependent Approach for Predicting Organic Anion-Transporting Polypeptide-Mediated Drug-Drug Interactions. Hu, Zhe-Yi // Clinical Pharmacokinetics;2013, Vol. 52 Issue 6, p433 

    Background and Objective: Organic anion-transporting polypeptide (OATP)-mediated drug-drug interactions (DDIs) are among the most important classes of clinically relevant DDIs. Accurate prediction of the OATP-mediated DDIs is not successful due to the sequential disposition pathways of OATP...

  • Erythromycin-induced Drug Interactions. Zitelli, Basil J.; Howrie, Denise L.; Altman, Harold; Maroon, Thomas J. // Clinical Pediatrics;Mar1987, Vol. 26 Issue 3, p117 

    The authors report a case of erythromycin-induced carbamazepine toxicity in a 6-year-old child following use of erythromycin ethylsuccinate (50 mg/kg/day). Within 5 days of erythromycin use, vomiting, weakness, lethargy, ataxia, nystagmus, and cogwheeling movements developed. A serum...

  • Pharmacokinetic Drug Interaction Studies with Enzalutamide. Gibbons, Jacqueline; Vries, Michiel; Krauwinkel, Walter; Ohtsu, Yoshiaki; Noukens, Jan; Walt, Jan-Stefan; Mol, Roelof; Mordenti, Joyce; Ouatas, Taoufik; Gibbons, Jacqueline A; de Vries, Michiel; van der Walt, Jan-Stefan // Clinical Pharmacokinetics;Oct2015, Vol. 54 Issue 10, p1057 

    Background and Objectives: Two phase I drug interaction studies were performed with oral enzalutamide, which is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC).Methods: A parallel-treatment design (n = 41) was used to evaluate...

  • Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in Indians. Chawla, Prerna; Nanday, Shweta; Dherai, Alpa; Soman, Rajeev; Lokhande, Rohan; Naik, Prasad; Ashavaid, Tester; Chawla, Prerna K; Nanday, Shweta R; Dherai, Alpa J; Lokhande, Rohan V; Naik, Prasad R; Ashavaid, Tester F // International Journal of Clinical Pharmacy;Oct2015, Vol. 37 Issue 5, p925 

    Background: Voriconazole is an antifungal drug essentially metabolized by cytochrome P450 (CYP2C19) isozyme. Plasma voriconazole levels exhibit wide inter-individual variability due to several factors like age, weight, food or drug interactions or CYP2C19...

  • Toxic clozapine serum levels during acute urinary tract infection: a case report. Jecel, Julia; Michel, Tanja; Gutknecht, Lise; Schmidt, Daniela; Pfuhlmann, Bruno; Jabs, Burkhard // European Journal of Clinical Pharmacology;Feb2005, Vol. 60 Issue 12, p909 

    Presents a case study of a woman, hospitalized for treatment of a manic and paranoid syndrome, who showed toxic clozapine serum levels during an acute urinary tract infection. Occurrence of toxic clozapine levels due to cytokein-mediated inhibition of cytochrome P450 in intercurrent bacterial...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics